Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
about
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Immune thrombocytopeniaChildhood immune thrombocytopenia: Clinical presentation and managementThe Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and PathogenesisImpact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia.Fatigue in adult patients with primary immune thrombocytopenia.Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.ITP: a historical perspective.Management of immune thrombocytopenic purpura in children: potential role of novel agents.Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial.The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura.Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids.Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim.Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study.Cognitive symptoms are common in immune thrombocytopenia and associate with autonomic symptom burden.CD72 gene expression in immune thrombocytopenia.Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura.Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin.Thrombocytopenia in the intensive care unit.Romiplostim: a review of its use in immune thrombocytopenia.An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP).Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia.A blinded study of bone marrow examinations in patients with primary immune thrombocytopeniaImmune thrombocytopenic purpura: historical perspective, current status, recent advances and future directions.The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP).Chronic immune thrombocytopenic purpura in childhood: pathogenetic mechanisms and management.Establishment of reference interval for immature platelet fraction.A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopeniaImmune thrombocytopenia -- what are the new treatment options?Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children.Contemporary treatment of immune thrombocytopenia.Effect of severe sepsis on platelet count and their indicesBone marrow examination in patients with immune thrombocytopenia: is there anything different in older patients?The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital.Aberrant frequency of IL-10-producing B cells and its association with Treg/Th17 in adult primary immune thrombocytopenia patients.A Seeming Paradox: Ischemic Stroke in the Context of Idiopathic Thrombocytopenic Purpura.
P2860
Q26824798-D6BAE537-DCC1-4690-90D6-AFC8060A4448Q26830918-ACF2B803-6E5C-4C36-8CE7-DF57222B1C03Q27023294-F546272D-2F5F-4BC0-945F-67BA0F4BB236Q28068881-F1B90CDF-BBC6-4722-A10E-E038EB990ADFQ30252123-D64F0195-7687-4C70-A0C7-A38D4C5EB318Q33391987-68BAA332-4B33-4FEB-B65F-7DA9FD6BFDDDQ33394156-99E2B60C-CDBE-4992-A33E-FF7FBCEA6188Q33394438-2CD5D2C5-FFA0-4449-B2A3-8FDFA83D33EEQ33394791-108EFBA0-13CE-439F-B397-20F29C0EFD7AQ33395863-B31551D6-156B-44B5-B852-384036BD58FEQ33395943-F295E19D-6CB3-46A4-82D9-EB20515F565AQ33396360-E0F60B58-8B3A-469C-A766-5F9023D70CEBQ33396799-9E71966D-3C2B-4220-AEA5-4428803F8950Q33397101-2A14F7C6-36E5-4D18-B859-B3DE90D83C8FQ33397133-67AC3EB5-64C6-46E7-A053-14BA0F81B0DCQ33397388-B208025E-CA4C-46BD-A9F8-0A76C7CFCB50Q33397931-06EDF551-44BC-4D1F-9C8E-7E2AB5AFA108Q33398413-0C754933-92BE-4438-B9EE-A3A139A06F68Q33398637-BEBEF906-E4E8-4BA5-99E4-F510BE785C2AQ33398769-E0307F71-D376-47AF-B69E-18A84E6C29E6Q33399094-3B64736A-B671-490E-8CB2-83D734E7BD8BQ33399598-6C7D81BF-CFA8-49CC-90A9-57F40BB9D254Q33400911-D374594E-F0AE-4CE3-B860-6AB901D9577CQ33403176-C652F69E-25AD-4A76-B170-8922F1C32AA9Q33403270-E356A110-60BB-48D4-B817-3991BFF4B59EQ33404293-D1973710-8E20-4E0A-84A0-F3DD4E103802Q33404315-33506E9D-FB66-4820-A29B-9506EE5BA70EQ33404408-95771EBE-290F-4A38-9A8E-79424972B4EAQ33404481-E417AD9B-2691-4478-AA6C-EB168A6FE1A7Q33405092-591800B7-E48B-4E37-A43B-5FAA38E533E4Q33406127-5890DD8F-623C-4CBA-9D73-99BFCEFDDD8DQ33407802-9D88DCA5-D7BC-47D4-B0E7-82AAAEA54F0FQ33409528-76A5D077-7690-4D42-BC19-F47CE1FCBDFCQ33410356-2EB0C471-3B01-4CEB-BCB5-52F84C280894Q33410653-E7668BA5-E978-4731-9842-51BCFA4BEDD9Q33411480-C933FC02-0AE4-4CC7-8777-531E4288B295Q33414164-603EBA5D-C718-4822-B642-577809C7097AQ33414420-C8761E0A-143B-432F-A445-28A773EDFD33Q33416700-112CB5D0-FFA6-4169-89CF-DCAFE509D5B0Q33417001-3C7521DE-1295-4890-AA6A-D31BB2FC46A7
P2860
Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pathogenesis of chronic immune ...... decreased platelet production.
@ast
Pathogenesis of chronic immune ...... decreased platelet production.
@en
type
label
Pathogenesis of chronic immune ...... decreased platelet production.
@ast
Pathogenesis of chronic immune ...... decreased platelet production.
@en
prefLabel
Pathogenesis of chronic immune ...... decreased platelet production.
@ast
Pathogenesis of chronic immune ...... decreased platelet production.
@en
P2093
P1476
Pathogenesis of chronic immune ...... decreased platelet production.
@en
P2093
Diane Nugent
Janet L Nichol
Robert McMillan
Sherrill J Slichter
P304
P356
10.1111/J.1365-2141.2009.07717.X
P407
P577
2009-05-14T00:00:00Z